Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 19.5B | 15.2B | 17.8B | 16.9B |
| Cost of revenue | 17.1B | 16.8B | 21.3B | 15.6B |
| Gross profit | 2.4B | -1.6B | -3.5B | 1.2B |
| Operating expense | ||||
| Research & development | 844M | 836M | 1.2B | 954M |
| Selling general and admin | 1.1B | 1.4B | 1.1B | 1.4B |
| Other operating expenses | — | — | — | — |
| Operating income | 461M | -3.8B | -5.7B | -1.1B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 708M | 755M | 728M | 673M |
| Other income expense | 323M | 485M | 250M | 260M |
| Pretax income | 76M | -4.1B | -6.2B | -1.5B |
| Tax provision | 107M | -232M | -50M | -76M |
| Net income | -31M | -3.9B | -6.2B | -1.4B |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 1.3B | -2.9B | -5.0B | -413M |
| Net income from continuing op. | -31M | -3.9B | -6.2B | -1.4B |
| Minority interests | -6M | -4M | 4M | — |
| Preferred stock dividends | — | — | — | — |